Predictive Biosciences raises $21.8M for cancer diagnostic tech
Predictive Biosciences, a company that hopes to improve the way cancer is diagnosed and monitored, announced that it brought in $21.8 million in second-round financing led by New Enterprise Associates and including contributions from Kaiser Permanente Ventures, Flybridge Venture Capital and Highland Capital Partners. This brings the company’s VC total up to $31.7 million since its inception in 2006.
The Lexington, Mass.-based company plans to use its new funds to complete clinical studies and launch new… Continue Reading